Posard Matthew L.

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$1.23M
Insider Sells Quantity
10
Insider Sells Sum
$5.27M

Insider Activity of Posard Matthew L.

According to the SEC Form 4 filings, Posard Matthew L., being in a position of

  1. director at Halozyme Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 49881 share for $2.7M,
    over all time since 2022-12-02, has bought 0 shares, and sold 79881 share for $4.4M.

The largest purchase of all time was on 2021-02-17 and amounted to 62500 shares of Talis Biomedical Corporation for $1M.

The largest sale of all time was on 2013-04-11 and amounted to 11550 shares of Illumina, Inc. for $669,323.

Biography of Posard Matthew L.

No biography is available at this moment.

2024-08-14SaleHalozyme Therapeutics, Inc.
HALO
director
9,881
0.0081%
$57.70$570,1340%
2024-08-13SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0079%
$56.19$561,9300%
2024-08-12SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0079%
$55.72$557,230+1.61%
2024-06-12SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.008%
$50.62$506,190+9.17%
2024-06-11SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0079%
$50.01$500,110+8.43%
2022-12-06SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0073%
$56.12$561,180-30.57%
2022-12-05SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0073%
$55.74$557,370-30.02%
2022-12-02SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0072%
$58.80$588,000-34.15%
2021-12-01PurchaseNautilus Biotechnology, Inc.
NAUT
director
30,000
0.0357%
$4.47$134,105-22.47%
2021-11-30PurchaseNautilus Biotechnology, Inc.
NAUT
director
20,000
0.0223%
$4.57$91,400-28.35%
2021-02-17PurchaseTalis Biomedical Corporation
TLIS
director
62,500
0.315%
$16.00$1M-65.14%
2013-05-30SaleIllumina, Inc.
ILMN
Sr VP & General Manager
2,836
0.0023%
$70.80$200,789+37.33%
2013-04-11SaleIllumina, Inc.
ILMN
Sr VP & General Manager
11,550
0.0093%
$57.95$669,323+41.9%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.